Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32984
Title: Immuno-oncology therapy associated thromboembolic events in metastatic renal cell carcinoma.
Austin Authors: Alhamdani, Zein;Alberto, Matthew;Ischia, Joseph J 
Affiliation: Surgery (University of Melbourne)
Issue Date: Jul-2023
Date: 2023
Publication information: Urology Case Reports 2023-07; 49
Abstract: The relationship between thromboembolic events (TEs) and immune-oncology (IO) agents in patients with metastatic renal cell carcinoma (mRCC) with inferior-vena-cava (IVC) thrombus has not been explored despite conferring significant morbidity. A late 30s female is diagnosed with mRCC with a level-II IVC thrombus after presenting with back pain. Two weeks post initiation of immunotherapy, she re-presented with bilateral sub-massive pulmonary emboli requiring IVC and pulmonary thrombectomy. This case exposes a potential relationship between mRCC and IVC thrombus with IO agents that creates a critically hypercoagulable state. This issue requires further investigation given the apparent under-reporting of TEs in these patients.
URI: https://ahro.austin.org.au/austinjspui/handle/1/32984
DOI: 10.1016/j.eucr.2023.102420
ORCID: 
Journal: Urology Case Reports
Start page: 102420
PubMed URL: 37215941
Type: Journal Article
Subjects: Case report
IVC thrombus
Immune-oncology
Immunotherapy
Metastatic renal cell carcinoma
Pulmonary embolism
Thromboembolic
Appears in Collections:Journal articles

Show full item record

Page view(s)

26
checked on May 30, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.